Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin Article

Bujold, E, Romero, R, Chaiworapongsa, T et al. (2005). Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin . Journal of Maternal-Fetal and Neonatal Medicine, 18(1), 9-16. 10.1080/14767050500202493

Open Access International Collaboration

cited authors

  • Bujold, E; Romero, R; Chaiworapongsa, T; Kim, YM; Kim, GJ; Kim, MR; Espinoza, J; Gonçalves, LF; Edwin, S; Mazor, M

sustainable development goals

authors

publication date

  • July 1, 2005

published in

keywords

  • ENDOTHELIAL GROWTH-FACTOR
  • FETAL-GROWTH
  • FLK-1/KDR ACTIVATION
  • GESTATIONAL HYPERTENSION
  • HUMAN EXTRAVILLOUS TROPHOBLAST
  • Life Sciences & Biomedicine
  • NITRIC-OXIDE
  • Obstetrics & Gynecology
  • PERIPHERAL CIRCULATIONS
  • PLACENTAL GROWTH
  • RENIN-ANGIOTENSIN SYSTEM
  • SIGNAL-TRANSDUCTION
  • Science & Technology
  • angiogenesis
  • placental growth factor (PlGF)
  • preeclampsia
  • soluble vascular endothelial growth factor receptor-1(sVEGFR-1)
  • uterine vein

Digital Object Identifier (DOI)

start page

  • 9

end page

  • 16

volume

  • 18

issue

  • 1